|
CA2295303A1
(en)
*
|
1997-06-27 |
1999-01-07 |
Human Genome Sciences Inc. |
Human nk-3 related prostate specific gene-1
|
|
KR100919593B1
(ko)
|
2000-06-29 |
2009-09-29 |
아보트 러보러터리즈 |
이중 특이성 항체 및 이의 제조 방법 및 이를 포함하는 조성물
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
DK1399484T3
(da)
*
|
2001-06-28 |
2010-11-08 |
Domantis Ltd |
Dobbelt-specifik ligand og anvendelse af denne
|
|
GB0115841D0
(en)
|
2001-06-28 |
2001-08-22 |
Medical Res Council |
Ligand
|
|
US7696320B2
(en)
|
2004-08-24 |
2010-04-13 |
Domantis Limited |
Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
|
|
US20070104710A1
(en)
*
|
2002-06-28 |
2007-05-10 |
Domants Limited |
Ligand that has binding specificity for IL-4 and/or IL-13
|
|
US20060002935A1
(en)
|
2002-06-28 |
2006-01-05 |
Domantis Limited |
Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
|
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
US9028822B2
(en)
|
2002-06-28 |
2015-05-12 |
Domantis Limited |
Antagonists against TNFR1 and methods of use therefor
|
|
USRE47770E1
(en)
|
2002-07-18 |
2019-12-17 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
|
NZ537277A
(en)
|
2002-07-18 |
2008-04-30 |
Crucell Holland Bv |
Recombinant production of mixtures of antibodies
|
|
US20050271660A1
(en)
*
|
2002-09-06 |
2005-12-08 |
Alexion Pharmaceuticals, Inc. |
Nebulization of monoclonal antibodies for treating pulmonary diseases
|
|
US20110223168A1
(en)
*
|
2002-12-27 |
2011-09-15 |
Greg Winter |
Ligand that has binding specificity for il-4 and/or il-13
|
|
GB0230201D0
(en)
*
|
2002-12-27 |
2003-02-05 |
Domantis Ltd |
Retargeting
|
|
ES2408582T3
(es)
|
2003-05-30 |
2013-06-21 |
Merus B.V. |
Biblioteca de Fab para la preparación de una mezcla de anticuerpos
|
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
|
JP4782700B2
(ja)
*
|
2004-01-20 |
2011-09-28 |
カロバイオス ファーマシューティカルズ インコーポレイティッド |
最低限必須な結合決定基を用いた抗体特異性の移入
|
|
DK1737971T3
(da)
|
2004-01-20 |
2017-11-13 |
Merus Nv |
Blandinger af bindingsproteiner
|
|
TWI439284B
(zh)
*
|
2004-04-09 |
2014-06-01 |
艾伯維生物技術有限責任公司 |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
US7514539B2
(en)
|
2004-04-26 |
2009-04-07 |
Centocor, Inc. |
Epitope directed selection of antibodies to murine tissue factor
|
|
US7790405B2
(en)
|
2004-04-26 |
2010-09-07 |
Centocor, Inc. |
Solution phase biopanning method using engineered decoy proteins
|
|
PL1747015T3
(pl)
*
|
2004-04-26 |
2013-03-29 |
Janssen Biotech Inc |
Selekcja typu biopanning w fazie ciekłej, z wykorzystaniem wytworzonych białek-przynęt
|
|
EA012622B1
(ru)
|
2004-06-01 |
2009-10-30 |
Домэнтис Лимитед |
Биспецифичные гибридные антитела с увеличенным периодом полувыведения из сыворотки
|
|
EP1851245B1
(en)
|
2005-01-26 |
2012-10-10 |
Amgen Fremont Inc. |
Antibodies against interleukin-1 beta
|
|
KR100675791B1
(ko)
*
|
2005-02-04 |
2007-02-02 |
제주대학교 산학협력단 |
육상어류양식장용 자동먹이공급시스템
|
|
AU2006245734C1
(en)
|
2005-05-12 |
2012-05-24 |
Crucell Holland B.V. |
Host cell specific binding molecules capable of neutralizing viruses and uses thereof
|
|
US20090130652A1
(en)
*
|
2005-06-23 |
2009-05-21 |
Crucell Holland B.V. |
Optimization of West Nile Virus Antibodies
|
|
HRP20140338T1
(hr)
|
2005-07-25 |
2014-06-20 |
Emergent Product Development Seattle, Llc |
Smanjenje broja b-stanica upotrebom molekula koje se specifiäśno vežu na cd37 i cd20
|
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
EP2500356A3
(en)
|
2005-08-19 |
2012-10-24 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
KR20130108481A
(ko)
|
2005-08-19 |
2013-10-02 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
CN101277974A
(zh)
|
2005-09-30 |
2008-10-01 |
阿伯特有限及两合公司 |
排斥性引导分子(rgm)蛋白质家族的蛋白质的结合结构域及其功能性片段和它们的用途
|
|
US20100015146A1
(en)
*
|
2005-10-14 |
2010-01-21 |
Novo Nordisk A/S |
Treating diabetes using inhibitors of il-1
|
|
BRPI0709977A2
(pt)
*
|
2006-04-14 |
2011-08-02 |
Novartis Ag |
uso de anticorpos de il-1 para o tratamento de distúrbios oftálmicos
|
|
WO2007141274A2
(en)
*
|
2006-06-06 |
2007-12-13 |
Crucell Holland B.V. |
Human binding molecules having killing activity against staphylococci and uses thereof
|
|
WO2007146968A2
(en)
|
2006-06-12 |
2007-12-21 |
Trubion Pharmaceuticals, Inc. |
Single-chain multivalent binding proteins with effector function
|
|
AU2007281479A1
(en)
*
|
2006-08-02 |
2008-02-07 |
California Institute Of Technology |
Methods and systems for detecting and/or sorting targets
|
|
WO2008027236A2
(en)
*
|
2006-08-30 |
2008-03-06 |
Genentech, Inc. |
Multispecific antibodies
|
|
CA2673592C
(en)
|
2006-12-20 |
2014-03-25 |
Xoma Technology Ltd. |
Methods for the treatment of il-1.beta. related diseases
|
|
WO2008082651A2
(en)
*
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Dual-specific il-1a/ il-1b antibodies
|
|
EP2679996A1
(en)
|
2007-05-31 |
2014-01-01 |
AbbVie Inc. |
Biomarkers predictive of the responsiveness to TNF-alfa inhibitors in autoimmune disorders
|
|
WO2009040562A1
(en)
|
2007-09-26 |
2009-04-02 |
Ucb Pharma S.A. |
Dual specificity antibody fusions
|
|
AU2008338421A1
(en)
|
2007-12-17 |
2009-06-25 |
Dyax Corp. |
Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
|
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
AU2009221916A1
(en)
*
|
2008-03-03 |
2009-09-11 |
Dyax Corp. |
Metalloproteinase 9 and metalloproteinase 2 binding proteins
|
|
WO2009111450A2
(en)
|
2008-03-03 |
2009-09-11 |
Dyax Corp. |
Metalloproteinase 9 binding proteins
|
|
EP2365003A1
(en)
|
2008-04-11 |
2011-09-14 |
Emergent Product Development Seattle, LLC |
CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
|
BRPI0910482A2
(pt)
|
2008-04-29 |
2019-09-24 |
Abbott Lab |
imunoglobinas de domínio variável duplo e usos das mesmas
|
|
US20100260668A1
(en)
*
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
|
PE20100092A1
(es)
|
2008-06-03 |
2010-03-12 |
Abbott Lab |
Inmunoglobulina con dominio variable dual y usos de la misma
|
|
BRPI0913366A8
(pt)
|
2008-06-03 |
2017-07-11 |
Abbott Lab |
Imunoglobulinas de domínio variável duplo e seus usos
|
|
NZ603698A
(en)
*
|
2008-07-08 |
2014-03-28 |
Abbvie Inc |
Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
|
|
CN102143977B
(zh)
|
2008-09-03 |
2014-08-06 |
霍夫曼-拉罗奇有限公司 |
多特异性抗体
|
|
EP2341936A4
(en)
*
|
2008-09-05 |
2012-07-25 |
Xoma Technology Ltd |
METHOD FOR TREATING OR PREVENTING IL-1ß-CONTAINED ILLNESSES
|
|
AU2009291536B2
(en)
*
|
2008-09-12 |
2012-08-16 |
Xbiotech Inc. |
Targeting pathogenic monocytes
|
|
HRP20170374T1
(hr)
|
2008-09-26 |
2017-05-05 |
Ucb Biopharma Sprl |
Biološki proizvodi
|
|
EP2196476A1
(en)
|
2008-12-10 |
2010-06-16 |
Novartis Ag |
Antibody formulation
|
|
SG172855A1
(en)
*
|
2009-01-29 |
2011-08-29 |
Abbott Lab |
Il-1 binding proteins
|
|
EP2403531A4
(en)
|
2009-03-05 |
2013-02-27 |
Abbott Lab |
IL-17 BINDING PROTEINS
|
|
PE20120591A1
(es)
*
|
2009-04-02 |
2012-05-23 |
Roche Glycart Ag |
Anticuerpos multiespecificos que comprenden anticuerpos de longitud completa y fragmentos fab de cadena sencilla
|
|
CN101957365B
(zh)
*
|
2009-07-21 |
2013-08-07 |
卫生部北京医院 |
检测抗环瓜氨酸肽和抗免疫球蛋白g双特异性抗体的试剂盒
|
|
UY32808A
(es)
*
|
2009-07-29 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas como dominio variable dual y usos de las mismas
|
|
WO2011025964A2
(en)
|
2009-08-29 |
2011-03-03 |
Abbott Laboratories |
Therapeutic dll4 binding proteins
|
|
KR20120060877A
(ko)
|
2009-09-01 |
2012-06-12 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
GB201005063D0
(en)
|
2010-03-25 |
2010-05-12 |
Ucb Pharma Sa |
Biological products
|
|
AU2010306677B2
(en)
*
|
2009-10-15 |
2013-05-23 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
IN2012DN02634A
(https=)
*
|
2009-10-15 |
2015-09-04 |
Abbvie Inc |
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
CN102656190A
(zh)
|
2009-12-08 |
2012-09-05 |
雅培股份有限两合公司 |
用于在视网膜神经纤维层变性治疗中使用的针对rgm a蛋白质的单克隆抗体
|
|
CA2786745A1
(en)
*
|
2010-01-12 |
2011-07-21 |
Oncomed Pharmaceuticals, Inc. |
Wnt-binding agents and uses thereof
|
|
BR112012021941A2
(pt)
|
2010-03-02 |
2022-02-01 |
Abbvie Inc |
Proteínas terapêuticas de ligação a dll4
|
|
CN102946906B
(zh)
|
2010-04-23 |
2015-07-15 |
弗·哈夫曼-拉罗切有限公司 |
生产异源多聚体蛋白质
|
|
KR101539684B1
(ko)
|
2010-05-14 |
2015-07-27 |
애브비 인코포레이티드 |
Ｉｌ－１ 결합 단백질
|
|
US20120009196A1
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
US8735546B2
(en)
|
2010-08-03 |
2014-05-27 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
RU2013110844A
(ru)
*
|
2010-08-13 |
2014-09-20 |
Дженентек, Инк. |
АНТИТЕЛА ПРОТИВ IL-1β И IL-18, ИСПОЛЬЗУЕМЫЕ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ
|
|
PE20140229A1
(es)
|
2010-08-26 |
2014-03-27 |
Abbvie Inc |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
CN103517921B
(zh)
|
2010-12-21 |
2017-07-18 |
Abbvie 公司 |
IL‑1‑α和‑β双特异性双重可变结构域免疫球蛋白及其用途
|
|
JP5918275B2
(ja)
*
|
2011-02-08 |
2016-05-18 |
アッヴィ・インコーポレイテッド |
変形性関節症及び疼痛の治療
|
|
US20140255405A1
(en)
|
2011-05-27 |
2014-09-11 |
Dutalys |
Removal of Monomeric Targets
|
|
AU2012265156B2
(en)
|
2011-05-27 |
2017-01-19 |
F. Hoffmann-La Roche Ag |
Dual targeting
|
|
AU2012274461A1
(en)
|
2011-06-20 |
2014-01-16 |
Kyowa Hakko Kirin Co., Ltd. |
Anti-erbB3 antibody
|
|
US10314909B2
(en)
|
2011-10-21 |
2019-06-11 |
Dyax Corp. |
Combination therapy comprising an MMP-14 binding protein
|
|
AU2012328917B2
(en)
|
2011-10-24 |
2017-05-25 |
Abbvie Inc. |
Bispecific immunobinders directed against TNF and IL-17
|
|
JP2014533659A
(ja)
|
2011-10-24 |
2014-12-15 |
アッヴィ・インコーポレイテッド |
スクレロスチンに対するイムノバインダー
|
|
CA2856582A1
(en)
*
|
2011-11-21 |
2013-05-30 |
Abbvie Inc. |
Il-1 binding proteins
|
|
RU2482181C1
(ru)
*
|
2011-12-07 |
2013-05-20 |
Учреждение Российской академии медицинских наук Российский онкологический научный центр имени Н.Н. Блохина РАМН |
Клеточная линия d11 множественной миеломы человека, используемая для гибридомной технологии
|
|
CN104144947B
(zh)
|
2011-12-14 |
2017-10-27 |
艾伯维德国有限责任两合公司 |
用于诊断和治疗铁相关病症的组合物和方法
|
|
EP2791175A2
(en)
|
2011-12-14 |
2014-10-22 |
Abbvie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
|
KR101963230B1
(ko)
|
2011-12-26 |
2019-03-29 |
삼성전자주식회사 |
복수개의 단일 항체를 포함하는 단백질 복합체
|
|
AR089529A1
(es)
|
2011-12-30 |
2014-08-27 |
Abbvie Inc |
Proteinas de union especificas duales dirigidas contra il-13 y/o il-17
|
|
US20130171059A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
NZ714482A
(en)
|
2012-01-27 |
2017-08-25 |
Abbvie Inc |
Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
|
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
|
SI2838917T1
(sl)
|
2012-04-20 |
2019-11-29 |
Merus Nv |
Postopki in sredstva za produkcijo heterodimernih IG-podobnih molekul
|
|
UY34905A
(es)
|
2012-07-12 |
2014-01-31 |
Abbvie Inc |
Proteínas de unión a il-1
|
|
KR101911438B1
(ko)
|
2012-10-31 |
2018-10-24 |
삼성전자주식회사 |
이중 특이 항원 결합 단백질 복합체 및 이중 특이 항체의 제조 방법
|
|
KR20180008921A
(ko)
|
2012-11-01 |
2018-01-24 |
애브비 인코포레이티드 |
항-ｖｅｇｆ／ｄｌｌ4 이원 가변 도메인 면역글로불린 및 이의 용도
|
|
EP3466973A1
(en)
*
|
2012-11-01 |
2019-04-10 |
AbbVie Inc. |
Stable dual variable domain immunoglobulin protein formulations
|
|
EP2928919A2
(en)
|
2012-12-04 |
2015-10-14 |
AbbVie Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins
|
|
US9856319B2
(en)
|
2012-12-28 |
2018-01-02 |
Abbvie Inc. |
Monovalent binding proteins
|
|
EP2938637A2
(en)
|
2012-12-28 |
2015-11-04 |
AbbVie Inc. |
Multivalent binding protein compositions
|
|
EP2938634A2
(en)
|
2012-12-28 |
2015-11-04 |
AbbVie Inc. |
Dual specific binding proteins having a receptor sequence
|
|
EP2948475A2
(en)
|
2013-01-23 |
2015-12-02 |
AbbVie Inc. |
Methods and compositions for modulating an immune response
|
|
CN105324396A
(zh)
|
2013-03-15 |
2016-02-10 |
艾伯维公司 |
针对IL-1β和/或IL-17的双重特异性结合蛋白
|
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
|
TW201446800A
(zh)
|
2013-03-15 |
2014-12-16 |
Abbvie Inc |
針對ＴＮＦα之雙特異性結合蛋白
|
|
US10183988B2
(en)
|
2013-06-07 |
2019-01-22 |
Duke University |
Anti-Complement factor H antibodies
|
|
CN103308697B
(zh)
*
|
2013-06-09 |
2014-11-26 |
卫生部北京医院 |
检测抗丙型肝炎病毒编码的非结构蛋白ns3和ns5的天然双特异性抗体的试剂盒
|
|
US9879081B2
(en)
|
2013-06-25 |
2018-01-30 |
Samsung Electronics Co., Ltd. |
Protein complex, bispecific antibody including the protein complex, and method of preparation thereof
|
|
KR20160055275A
(ko)
|
2013-09-17 |
2016-05-17 |
유니버시티 헬스 네트워크 |
시스 ｒｇｍａ/네오제닌 상호작용 또는 지질 래프트에 대해 지시되는 제제 및 치료 방법에서의 이의 용도
|
|
CA2922950A1
(en)
|
2013-09-30 |
2015-04-02 |
Shinya Ishii |
Method for producing antigen-binding molecule using modified helper phage
|
|
EP3083682B1
(en)
*
|
2013-12-20 |
2024-04-17 |
F. Hoffmann-La Roche AG |
Dual specific antibodies
|
|
CA2943707A1
(en)
|
2014-05-06 |
2015-11-12 |
Genentech, Inc. |
Production of heteromultimeric proteins using mammalian cells
|
|
US20160000936A1
(en)
|
2014-06-10 |
2016-01-07 |
Abbvie Inc. |
Biomarkers for inflammatory disease and methods of using same
|
|
WO2015191934A2
(en)
|
2014-06-11 |
2015-12-17 |
Abbvie Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
|
|
EP2985294A1
(en)
|
2014-08-14 |
2016-02-17 |
Deutsches Krebsforschungszentrum |
Recombinant antibody molecule and its use for target cell restricted T cell activation
|
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
|
JP6655302B2
(ja)
*
|
2015-05-29 |
2020-02-26 |
デンカ生研株式会社 |
被検対象の検出方法並びにそのための免疫測定器具及びモノクローナル抗体
|
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
|
|
WO2017044862A1
(en)
|
2015-09-11 |
2017-03-16 |
Abbvie Inc. |
Methods for treating relapsing forms of multiple sclerosis
|
|
EP3352760B1
(en)
|
2015-09-21 |
2026-03-11 |
Aptevo Research and Development LLC |
Cd3 binding polypeptides
|
|
CN108139394B
(zh)
*
|
2015-10-02 |
2020-10-30 |
豪夫迈·罗氏有限公司 |
用于确定同时结合的基于细胞的fret测定法
|
|
NZ739090A
(en)
|
2015-10-02 |
2025-06-27 |
Hoffmann La Roche |
Bispecific antibodies specific for pd1 and tim3
|
|
WO2017087784A1
(en)
|
2015-11-18 |
2017-05-26 |
Duke University |
Tumor infiltrating lymphocytes for treatment of cancer
|
|
WO2017156500A1
(en)
|
2016-03-11 |
2017-09-14 |
Scholar Rock, Inc. |
Tgfb1-binding immunoglobulins and use thereof
|
|
CN109496218A
(zh)
|
2016-06-01 |
2019-03-19 |
艾伯维公司 |
用于治疗脊髓损伤和疼痛的抗反义导向分子a（rgma）拮抗性抗体
|
|
US20190225701A1
(en)
|
2016-09-26 |
2019-07-25 |
The Brigham And Women's Hospital, Inc. |
Regulators of b cell-mediated immunosuppression
|
|
JP2019535015A
(ja)
|
2016-10-03 |
2019-12-05 |
アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ |
患者サンプルにおけるｇｆａｐ状況を評価する改善された方法
|
|
PE20191661A1
(es)
|
2017-01-06 |
2019-11-11 |
Scholar Rock Inc |
Inhibidores de tgf beta1 isoforma-especificos contexto-permisivos y uso de los mismos
|
|
US11016092B2
(en)
|
2017-03-23 |
2021-05-25 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1
|
|
RU2761377C2
(ru)
|
2017-04-03 |
2021-12-07 |
Ф. Хоффманн-Ля Рош Аг |
Иммуноконъюгаты антитела к pd-1 с мутантом il-2 или с il-15
|
|
TWI690538B
(zh)
|
2017-04-05 |
2020-04-11 |
瑞士商赫孚孟拉羅股份公司 |
特異性結合至pd1至lag3的雙特異性抗體
|
|
BR112019021612A2
(pt)
|
2017-04-15 |
2020-05-12 |
Abbott Laboratories |
Métodos para auxiliar o diagnóstico hiperagudo e determinação de traumatismo crânioencefálico em um indivíduo humano com o uso de biomarcadores precoces
|
|
US10877038B2
(en)
|
2017-04-28 |
2020-12-29 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
|
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
|
JP7416625B2
(ja)
|
2017-05-25 |
2024-01-17 |
アボット・ラボラトリーズ |
早期バイオマーカーを使用する、頭部への損傷を負ったヒト対象又は負った可能性があるヒト対象に対して、イメージングを実施するかどうかの決定の一助となるための方法
|
|
BR112019025313A2
(pt)
|
2017-05-30 |
2020-06-23 |
Abbott Laboratories |
Métodos para auxílio no diagnóstico e avaliação de uma lesão cerebral traumática leve em um indivíduo humano usando troponina cardíaca i
|
|
JP7454945B2
(ja)
|
2017-07-03 |
2024-03-25 |
アボット・ラボラトリーズ |
血液中のユビキチンカルボキシ末端ヒドロラーゼｌ１レベルを測定するための、改善された方法
|
|
GB201711208D0
(en)
|
2017-07-12 |
2017-08-23 |
Iontas Ltd |
Ion channel inhibitors
|
|
KR102782136B1
(ko)
|
2017-11-08 |
2025-03-18 |
쿄와 기린 가부시키가이샤 |
CD40과 EpCAM에 결합하는 이중특이적 항체
|
|
US11022617B2
(en)
|
2017-12-09 |
2021-06-01 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)
|
|
US11016105B2
(en)
|
2017-12-09 |
2021-05-25 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
|
|
CA3084064A1
(en)
|
2017-12-29 |
2019-07-04 |
Abbott Laboratories |
Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
|
|
PL3677278T3
(pl)
|
2018-07-11 |
2022-02-28 |
Scholar Rock, Inc. |
Selektywne względem izoformy inhibitory tgfbeta1 i ich zastosowanie
|
|
MX2021000347A
(es)
|
2018-07-11 |
2021-04-19 |
Scholar Rock Inc |
Inhibidores de tgf?1 selectivos de isoforma, de alta afinidad y usos de los mismos.
|
|
TW202019957A
(zh)
|
2018-07-11 |
2020-06-01 |
美商供石公司 |
TGFβ1抑制劑及其用途
|
|
JP7506607B2
(ja)
|
2018-12-28 |
2024-06-26 |
協和キリン株式会社 |
ＴｆＲに結合するバイスペシフィック抗体
|
|
WO2020180695A1
(en)
|
2019-03-01 |
2020-09-10 |
Abbott Laboratories |
Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
|
|
WO2020230899A1
(ja)
|
2019-05-15 |
2020-11-19 |
協和キリン株式会社 |
Ｃｄ４０とｆａｐに結合するバイスペシフィック抗体
|
|
WO2020230901A1
(ja)
|
2019-05-15 |
2020-11-19 |
協和キリン株式会社 |
Ｃｄ４０とｇｐｃ３に結合するバイスペシフィック抗体
|
|
AU2021205440A1
(en)
|
2020-01-11 |
2022-09-01 |
Scholar Rock,Inc. |
TGF-beta inhibitors and use thereof
|
|
US20230057012A1
(en)
|
2020-01-11 |
2023-02-23 |
Scholar Rock, Inc. |
Tgfb inhibitors and use thereof
|
|
WO2021211331A1
(en)
|
2020-04-13 |
2021-10-21 |
Abbott Point Of Care Inc. |
METHODS, COMPLEXES AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF A ß-CORONAVIRUS ANTIBODY IN A SAMPLE
|
|
CN111793131A
(zh)
*
|
2020-05-11 |
2020-10-20 |
廊坊天光生物技术有限公司 |
一种用于检测血清中pf4含量的抗体对及其用途
|
|
WO2021231798A1
(en)
|
2020-05-13 |
2021-11-18 |
Disc Medicine, Inc. |
Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis
|
|
WO2022031804A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Laboratories |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
US20220170948A1
(en)
|
2020-12-01 |
2022-06-02 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi
|
|
EP4271998A1
(en)
|
2020-12-30 |
2023-11-08 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
|
WO2022204581A2
(en)
|
2021-03-26 |
2022-09-29 |
Scholar Rock, Inc. |
Tgf-beta inhibitors and use thereof
|
|
EP4341699A1
(en)
|
2021-05-18 |
2024-03-27 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
|
WO2022256723A2
(en)
|
2021-06-03 |
2022-12-08 |
Scholar Rock, Inc. |
Tgf-beta inhibitors and therapeutic use thereof
|
|
JP2024521476A
(ja)
|
2021-06-14 |
2024-05-31 |
アボット・ラボラトリーズ |
音響エネルギー、電磁エネルギー、過圧波及び／又は爆風により引き起こされる脳損傷の診断法又は診断の一助となる方法
|
|
EP4370148A1
(en)
|
2021-07-14 |
2024-05-22 |
Scholar Rock, Inc. |
Ltbp complex-specific inhibitors of tgf beta1 and uses thereof
|
|
WO2023019019A2
(en)
*
|
2021-08-13 |
2023-02-16 |
Abwiz Bio, Inc. |
Humanization, affinity maturation, and optimization methods for proteins and antibodies
|
|
CN118715440A
(zh)
|
2021-08-31 |
2024-09-27 |
雅培实验室 |
诊断脑损伤的方法和系统
|
|
AU2022339759A1
(en)
|
2021-08-31 |
2024-03-07 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
|
WO2023056268A1
(en)
|
2021-09-30 |
2023-04-06 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
|
AU2022413677A1
(en)
|
2021-12-17 |
2024-06-27 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
|
KR20240139074A
(ko)
|
2022-02-04 |
2024-09-20 |
애벗트 라보라토리이즈 |
샘플에서 유비퀴틴 카르복시-말단 히드롤라제 l1 및/또는 신경교 섬유성 산성 단백질의 존재를 검출하거나 또는 그의 양을 측정하기 위한 측면 유동 방법, 검정 및 기기
|
|
JP2025524496A
(ja)
|
2022-06-29 |
2025-07-30 |
アボット・ラボラトリーズ |
生体試料におけるｇｆａｐを決定するための磁気ポイントオブケアシステム及びアッセイ
|
|
KR20250068723A
(ko)
|
2022-09-15 |
2025-05-16 |
아보트 러보러터리즈 |
경증 및 초경증 외상성 뇌 손상을 구분하기 위한 바이오마커 및 방법
|
|
WO2024187051A1
(en)
|
2023-03-07 |
2024-09-12 |
Scholar Rock, Inc. |
Tgf-beta inhibitors for use for treating resistant or unresponsive cancer in patients
|
|
WO2024211475A1
(en)
|
2023-04-04 |
2024-10-10 |
Abbott Laboratories |
Use of biomarkers to determine whether a subject has sustained, may have sustained or is suspected of sustaining a subacute acquired brain injury (abi)
|
|
EP4713682A1
(en)
|
2023-04-28 |
2026-03-25 |
Abbott Point of Care Inc. |
Improved assays, cartridges, and kits for detection of biomarkers, including brain injury biomarkers
|
|
WO2025109206A1
(en)
|
2023-11-22 |
2025-05-30 |
Mabylon Ag |
Multispecific anti-allergen antibodies and uses thereof
|
|
WO2025108551A1
(en)
|
2023-11-23 |
2025-05-30 |
Mabylon Ag |
Multispecific anti-allergen antibodies and uses thereof
|
|
WO2025230857A1
(en)
|
2024-05-01 |
2025-11-06 |
Abbott Laboratories |
Improved methods for determining cardiac myosin binding protein c in biological samples
|